肝胆期MRI对规划影像引导肝脏肿瘤消融的影响
回顾性研究纳入34例患者共36次肝脏MRI检查(钆塞酸二钠增强),评估肝胆期图像在62个肝脏肿瘤经影像引导热消融规划中的影响。肝胆期图像使50%检查的胆管可见分支等级至少提高一级(p<0.0001),41.7%消融操作的介入决策受显著影响(p<0.0001),其中16.7%技术方案改变(p=0.005)。技术成功60/62(97%),4/36(11%)出现轻度(1级)不良事件,无胆道并发症。
要点
- 肝胆期图像使50%检查的胆管可见分支等级至少提高一级,有助于识别胆管解剖。
- 41.7%消融操作的介入决策受肝胆期图像显著影响,16.7%技术方案因此改变。
- 技术成功60/62(97%),轻度(1级)不良事件4/36(11%),无胆道并发症。
核心结论
- 在本中心实践中,使用钆塞酸二钠增强肝脏MRI的肝胆期图像影响了影像引导肝脏肿瘤消融的时机与方式。
研究设计与样本
- 经机构审查委员会批准的回顾性研究,纳入34例患者(男21例、女13例,年龄25-80岁),共36次肝脏MRI检查(钆塞酸二钠增强),均在36次影像引导热消融操作前12周内完成,共治疗62个肝脏肿瘤。
关键影像表现/征象
- 肝胆期图像上胆管可见性按分支等级细分,与标准MRI序列图像比较,由一名腹部放射科主治医师和一名研究员评估。
- 肝胆期图像使18/36(50%)检查的胆管可见分支等级至少提高一级(p<0.0001)。
诊断标准与关键数值
- 介入决策(是否消融及技术方案)由消融医师比较肝胆期图像与标准MRI序列后判定,15/36(41.7%)消融操作的介入决策受显著影响(p<0.0001)。
- 其中6/36(16.7%)操作的技术方案发生改变(p=0.005)。
临床应用与阅片要点
- 本研究中心的做法是使用钆塞酸二钠增强肝脏MRI的肝胆期图像规划影像引导肝脏肿瘤消融,该图像影响了消融时机与方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the impact of hepatobiliary phase images obtained during intravenous gadoxetate disodium-enhanced liver MRI in the planning of image-guided liver tumor ablations.
METHODS: This institutional review board-approved retrospective study included 34 patients (21 men, 13 women, ages 25-80) who underwent 36 liver MRI examinations with gadoxetate disodium within 12 weeks prior to image-guided thermal ablation of 62 liver tumors during 36 procedures. Visibility of bile ducts, subdivided by branch order, on hepatobiliary phase images was compared to standard MRI sequence images by an attending abdominal radiologist and fellow. Interventional decision making (whether or not to ablate and technical plan) using hepatobiliary phase images was compared with standard MRI sequences by the ablationists. The technical success and adverse events of ablation procedures were noted.
RESULTS: Bile duct visibility was significantly increased by at least one branch order in 18/36 (50%) examinations (p < 0.0001). Interventional decisions were significantly impacted in 15 (41.7%) of 36 ablation procedures (p < 0.0001), including changes to the technical plan in six (16.7%) of these procedures (p = 0.005). Technical success was achieved for 60/62 (97%) of tumors. Mild (grade 1) adverse events occurred in 4/36 (11%) procedures; no biliary complications occurred.
CONCLUSIONS: Use of hepatobiliary phase images obtained during gadoxetate disodium-enhanced liver MRI impacted both when and how to perform image-guided liver tumor ablations in our practice.
引用
- Shyn PB, O'Neill AC, Wiggins WF, et al. Hepatobiliary phase MRI: impact on planning image-guided liver tumor ablations. Abdom Radiol (NY). 2017. PMID: 28349225. doi:10.1007/s00261-017-1112-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。